Fingerprint
Dive into the research topics of 'Dipeptidyl peptidase IV (DPP IV) inhibitors: A newly emerging drug class for the treatment of type 2 diabetes'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Dipeptidyl peptidase IV (DPP IV) inhibitors: A newly emerging drug class for the treatment of type 2 diabetes
Brian D. Green*, Peter R. Flatt, Clifford J. Bailey
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review